A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
Y C KimJ Y YangJ S YoonSeong Jin JoH H AhnK H SongD-Y LeeK-Y ChungY-H WonIl-Hwan KimPublished in: The British journal of dermatology (2018)
Ingenol mebutate is effective for the treatment of AK in Asians, with tolerable safety profiles.